14 Leading Health Tech Angel Investors You Should Know
Looking for health tech funding? We've compiled a list of 14 active angel investors to help you find the right partner for your startup's next stage.
Rho Editorial Team
Angel investor funding can provide the initial capital needed to develop your product, run clinical trials, and build your team.
For example, angel investors like Paul Walker, Christopher Dean, Ryan Harris, and William Ford are notable backers of various startups in the health technology space.
Whether you are currently raising or have just closed a round, a platform like Rho can help you manage your new capital.
Our platform provides FDIC-insured accounts, corporate cards with up to 2% cashback, automated bill pay, spend controls, and real-time accounting integrations.
For founders in health tech, finding the right early capital can shape your startup's trajectory. Angel investors are often the first check in, providing not just funding but critical early support.
Unlike venture capital firms, angels invest their personal funds and can offer direct mentorship. This personal connection makes identifying the right individual investor a key step in your fundraising process.
To help you get started, we've curated this overview of notable angel investors in health tech, digital health, and medtech. Use this guide to identify individuals who may align with your company's vision.
Just raised or about to? Set up your financial stack with Rho in minutes. Rho provides business banking, corporate cards, accounting integrations and more—built for startup teams moving fast.
Top Health Tech Angel Investors By Stage
Health tech angel investors often focus on pre-seed and seed rounds, as this allows them to provide foundational support. Understanding who invests at these stages can help you connect with the right people for your company.
Pre-seed Angel Investors in Health Tech
Pre-seed is the earliest funding stage, often used to validate a concept and build a minimum viable product before seeking larger rounds. For example, investors like Brian Reilly focus on this initial stage, providing the first capital to get ideas off the ground.
Seed Stage Angel Investors in Health Tech
Seed funding is the first official equity round, providing capital to fine-tune your product, conduct market research, and expand your team. As one of the earliest startup funding types, it's a critical step, with investors like Blake Mycoskie, Christopher Dean, and David Schwab active in the health tech space.
Series A Angel Investors in Health Tech
A Series A round helps a startup with an established user base and consistent revenue to scale its operations and optimize its market position. You might look to individuals like Anton Levy, Bryan Roberts, and Vijay Pande for this stage of funding.
Series B Angel Investors in Health Tech
Series B funding is for companies that are past the development stage and ready to expand their market reach, taking the business to the next level through subsequent series funding rounds. Some notable investors in this space are Paul Walker, William Ford, and Richard Wells.
As you find angel investors, keep in mind that many are not limited to a single stage and may invest opportunistically. Some, like Vijay Pande, invest across the spectrum from seed to later rounds, adapting to a startup's needs as it grows.
Here is a closer look at prominent angel investors in the health tech sector. You'll find key details on their investment stages, areas of focus, location, and what makes each investor a compelling partner for founders.
1. Paul Walker
Paul Walker is a partner at the venture capital firm New Enterprise Associates (NEA), where he helps lead the firm's healthcare investing practice. He tends to invest in later-stage companies, bringing the resources of a major institutional investor to the table.
He concentrates on Series A and B rounds, with a substantial investment range that signals his involvement in significant funding efforts. His portfolio shows a strong interest in biopharmaceuticals, with investments in companies like Allakos and Geron.
Founders with established companies in the biotech and pharmaceutical sectors seeking to scale would be a good match. He is a good fit for teams looking for an institutional partner for their Series A or B financing.
- Investment stages: Series A, Series B
- Industries of focus: BioTech, Pharmaceuticals, Health IT, Health & Hospital Services
- Geographical presence: Menlo Park, California
- Ideal investment range: $2.0M - $50.0M
- Notable portfolio companies: Allakos, Geron, Xenon Pharmaceuticals
- Portfolio size: Over 20 investments
You can find more information about Paul Walker on the NEA website or his Crunchbase profile.
2. Christopher Dean
Christopher Dean is a managing director at the growth equity firm Summit Partners. While he invests across many industries, his portfolio includes activity in the health tech space, backed by the resources of a major firm.
A key aspect of his approach is his involvement in both seed and Series B rounds, showing a flexibility to support companies at different growth points. His investments span a wide range of sectors, from digital health and biotech to e-commerce and fintech, with portfolio companies like ShipMonk and Brooklinen.
He could be a good match for founders in high-growth sectors who are looking for a partner with the backing of a major institutional firm. His wide investment range suggests he is a fit for companies seeking significant capital for either their seed or Series B rounds.
- Investment stages: Seed, Series B
- Industries of focus: Digital Health, Health IT, E-commerce, FinTech, BioTech
- Geographical presence: Boston, Massachusetts
- Ideal investment range: $5.0M - $50.0M
- Notable portfolio companies: ShipMonk, Brooklinen, Celcoin
You can find more information about Christopher Dean on his LinkedIn or the Summit Partners website.
3. Ryan Harris
Ryan Harris is a General Partner at Norwest Venture Partners, bringing a unique combination of medical and investment experience. His background as a physician and researcher heavily influences his work in the health tech sector.
A key attribute is his ability to invest across both seed and Series B stages, offering support for companies at different points of their growth. His portfolio includes companies like Crossover Health and Onsite Dental, reflecting an interest in consumer health and health services.
He is a good match for founders building companies with a strong clinical or research foundation. Teams seeking a partner with deep medical expertise and the institutional backing of a firm like Norwest would find him a compelling investor.
- Investment stages: Seed, Series B
- Industries of focus: Consumer Health, Pharmaceuticals, Health & Hospital Services, Health IT
- Geographical presence: San Francisco, California
- Ideal investment range: $1.0M - $30.0M
- Notable portfolio companies: Crossover Health, Onsite Dental
You can find more information about Ryan Harris on his LinkedIn or the Norwest Venture Partners website.
4. William Ford
William Ford is the Chairman and CEO of the global growth equity firm General Atlantic. He operates at the institutional level, bringing the resources and strategic oversight of a major firm to his investments.
His investment activity is characterized by a clear focus on later-stage, Series B rounds that require significant capital. With a portfolio that includes large-scale companies like Reliance Retail and Reliance Jio, his approach is geared toward backing established businesses ready for major expansion.
Ford is a good match for founders leading well-established companies with proven market traction. If you are seeking a substantial capital partner for a Series B round to accelerate your company's growth, his firm is a compelling option.
- Investment stages: Series B
- Industries of focus: Health & Hospital Services, Digital Health, FinTech, Retail, Marketplaces
- Geographical presence: New York City
- Ideal investment range: $20.0M - $100.0M
- Notable portfolio companies: Reliance Retail, Reliance Jio, IHS Markit
You can find more information about William Ford on his LinkedIn or the General Atlantic website.
5. Blake Mycoskie
Blake Mycoskie is best known as the founder of TOMS and is an active angel investor. He invests his personal capital, bringing his extensive experience as a brand-builder to early-stage companies.
He primarily focuses on seed-stage investments, often with a consumer-facing angle. His portfolio includes health-focused companies like TARA Mind alongside popular brands like Athletic Brewing, showing an interest in mission-driven founders.
Mycoskie is a great match for founders at the seed stage who are building a strong brand identity and community. His background is particularly valuable for those in the consumer health and wellness space.
- Investment stages: Seed
- Industries of focus: Digital Health, BioTech, Health & Hospital Services, Fashion
- Geographical presence: Los Angeles, California
- Ideal investment range: $5K - $50K
- Notable portfolio companies: TARA Mind, Athletic Brewing, Liquid Death
You can find more information about Blake Mycoskie on his website or LinkedIn.
6. Thomas Jennings
Thomas Jennings is a Managing Director at the growth equity firm Summit Partners, where he has been investing for over two decades. He brings the resources and strategic guidance of a major institutional investor to his portfolio companies.
His investment activity centers on Series B rounds, signaling a focus on companies that are established and ready to scale. While his interests include health tech and biotech, his portfolio also shows activity in areas like SMB software, with investments in companies such as Accedian.
Jennings is a good match for founders who have proven their business model and are seeking a significant capital partner for their Series B financing. Teams looking for an investor with deep experience in growth equity would find him to be a strong potential partner.
- Investment stages: Series B
- Industries of focus: Health & Hospital Services, Digital Health, BioTech, Health IT, SMB Software
- Geographical presence: Boston, Massachusetts
- Ideal investment range: $5.0M - $50.0M
- Notable portfolio companies: Accedian, PeerApp
You can find more information about Thomas Jennings on the Summit Partners website or his LinkedIn.
7. Ryan McDonald
Ryan McDonald is a partner at Norwest Venture Partners, where he invests in health tech companies. He brings the institutional backing of a major venture firm to his portfolio, supporting founders with significant resources.
A notable aspect of his approach is his flexibility, investing in both seed and Series B rounds. His portfolio, which includes companies like Onsite Dental, shows an interest in consumer-facing health services and health IT.
He is a good match for founders building companies in the consumer health sector who need a partner for early or growth-stage funding. Teams seeking an investor with institutional support and a focus on health services would find him a compelling connection.
- Investment stages: Seed, Series B
- Industries of focus: Consumer Health, Pharmaceuticals, Health IT, Health & Hospital Services
- Geographical presence: San Francisco, California
- Ideal investment range: $1.0M - $30.0M
- Notable portfolio companies: Onsite Dental, Scratch
You can find more information about Ryan McDonald on the Norwest Venture Partners website or his LinkedIn.
8. Michael Dixon
Michael Dixon is a partner at the growth equity firm Transform Capital. He invests in later-stage companies, bringing the strategic support of an institutional firm to his portfolio.
He concentrates on Series B rounds, backing companies that are poised for significant growth. His portfolio shows a clear interest in health tech, with investments in companies like Nayya, Cleo, and Datavant.
Dixon is a good match for founders who have already found product-market fit and are raising a Series B to scale. If your company operates in health IT or SaaS and needs a partner for its growth stage, he could be a strong ally.
- Investment stages: Series B
- Industries of focus: Health & Hospital Services, Health IT, SaaS, Consumer Internet
- Geographical presence: San Francisco, California
- Ideal investment range: $10K - $50K
- Notable portfolio companies: Nayya, Cleo, Datavant
- Portfolio size: Over 30 investments
You can find more information about Michael Dixon on his LinkedIn or the Transform Capital website.
9. Anton Levy
Anton Levy is a Co-President and Chairman of the Global Technology Group at General Atlantic. He brings the resources of a major growth equity firm to his investments, operating at an institutional level.
A key aspect of his approach is his activity in both seed and Series A rounds, often with a significant investment range. His portfolio includes companies like A Place for Mom, Squarespace, and Chronosphere, showing his interest spans consumer health, enterprise software, and digital platforms.
Levy is a good match for founders leading high-growth companies that require substantial capital, even at an early stage. His broad industry focus makes him a compelling partner for ambitious teams in health tech, fintech, and consumer internet.
- Investment stages: Seed, Series A
- Industries of focus: Digital Health, Health & Hospital Services, FinTech, Enterprise, Consumer Internet
- Geographical presence: New York, New York
- Ideal investment range: $20.0M - $100.0M
- Notable portfolio companies: A Place for Mom, Squarespace, Chronosphere
- Portfolio size: Over 35 investments
You can find more information about Anton Levy on his LinkedIn or the General Atlantic website.
10. Richard Wells
Richard Wells is a Managing Director at Insight Partners, a global venture capital and private equity firm. He brings the resources of a major institutional investor to his portfolio companies, focusing on growth-stage software businesses.
He invests across both Series A and Series B rounds, with a significant investment range that signals his involvement in major funding efforts. His portfolio includes health tech companies like Eden Health but also extends to enterprise software and developer tools, showing a focus on high-growth software models.
Wells is a good match for founders leading established software companies that are ready to scale. If you are raising a Series A or B and need an institutional partner with deep experience in enterprise software, he is a strong potential investor.
- Investment stages: Series A, Series B
- Industries of focus: Health IT, Health & Hospital Services, Enterprise, Cloud Infrastructure, Cybersecurity
- Geographical presence: New York, New York
- Ideal investment range: $10.0M - $350.0M
- Notable portfolio companies: Eden Health, Sonar, OneTrust
- Portfolio size: Over 20 investments
You can find more information about Richard Wells on the Insight Partners website or his LinkedIn.
11. Bryan Roberts
Bryan Roberts is a partner at the venture capital firm Venrock, where he has been a key figure in the firm's healthcare investments for over two decades. His extensive experience and scientific background make him a well-regarded investor in the health tech community.
A defining characteristic is his deep scientific expertise, holding a PhD in Chemistry and Chemical Biology from Harvard. This informs his investments in technically complex areas like biotech and medical devices, with a portfolio that includes companies like Lyra Health and Element Biosciences.
He is an excellent match for founders with a strong scientific or research-driven approach to solving problems in healthcare. If you are raising a Series A or B and value an investor who can grasp deep technical details, he is a compelling partner.
- Investment stages: Series A, Series B
- Industries of focus: BioTech, Medical Devices, Health IT, Health & Hospital Services
- Geographical presence: San Francisco, California
- Ideal investment range: $2.0M - $40.0M
- Notable portfolio companies: Lyra Health, Suki, Element Biosciences
- Portfolio size: Over 95 investments
You can find more information about Bryan Roberts on the Venrock website or his LinkedIn.
12. Vijay Pande
Vijay Pande is a General Partner at Andreessen Horowitz (a16z), where he leads the firm’s investments in companies at the intersection of biology and computer science. His background as a Stanford professor and founder of the Folding@home project gives him a unique, deeply technical perspective.
A notable attribute is his flexibility to invest across the startup lifecycle, from seed to later stages. His portfolio, which includes companies like Devoted Health and Genesis Therapeutics, shows a clear focus on applying computational methods to solve complex biological problems.
Pande is an excellent match for founders with strong scientific or engineering backgrounds who are building technically complex companies. If you are looking for a partner who can provide both capital and credible scientific guidance, he is a compelling investor to consider.
- Investment stages: Seed, Series A, Series B
- Industries of focus: BioTech, Digital Health, Health IT, Pharmaceuticals, Health & Hospital Services
- Geographical presence: San Francisco, California
- Ideal investment range: $100K - $10.0M
- Notable portfolio companies: Devoted Health, Levels, Genesis Therapeutics
- Portfolio size: Over 35 investments
You can find more information about Vijay Pande on the a16z website or his LinkedIn.
13. Brian Reilly
Brian Reilly is a partner at the venture capital firm Will Ventures, where he brings his experience as an investor and founder to early-stage companies. He concentrates on pre-seed and seed rounds, providing foundational capital to get new ideas off the ground.
A key characteristic of his approach is an interest in the intersection of health, wellness, and consumer technology. His portfolio includes companies like Ness, a wellness company, and Aktivate, which focuses on sports management, highlighting this theme.
Reilly is a good match for founders at the earliest stages who are building companies in digital health, wellness, or sports tech. Teams looking for a partner with a founder's perspective and a focus on pre-seed and seed funding would find him a compelling investor.
- Investment stages: Pre-seed, Seed
- Industries of focus: Digital Health, Wellness & Fitness, Health IT, AI, Entertainment & Sports
- Geographical presence: Brooklyn, New York
- Ideal investment range: $100K - $5.0M
- Notable portfolio companies: Ness, Aktivate
You can find more information about Brian Reilly on his LinkedIn or the Will Ventures website.
14. David Schwab
David Schwab is a Managing Director at Sierra Ventures, bringing decades of experience and the resources of an established venture firm to his investments. He operates at the institutional level, supporting early-stage companies with strategic guidance.
He has a clear focus on seed-stage funding, backing companies across health IT, AI, and e-commerce. His investment in companies like Concert Health and WhizAI highlights an interest in businesses applying technology to solve healthcare challenges.
Schwab is a good match for founders at the seed stage who are building technology-driven companies, particularly in health IT. Teams seeking an experienced institutional partner for their first major funding round would find him a compelling option.
- Investment stages: Seed
- Industries of focus: Health & Hospital Services, E-commerce, Health IT, AI, Social Networks
- Geographical presence: Menlo Park, California
- Ideal investment range: $100K - $10.0M
- Notable portfolio companies: Concert Health, WhizAI, OnsiteIQ
- Portfolio size: Over 28 investments
You can find more information about David Schwab on his LinkedIn or Crunchbase profile.
What Startup Founders Should Look for in a Health Tech Investor
Finding the right health tech investor is about more than capital; it's about a partner whose expertise aligns with your needs. As this list shows, many investors have specific interests, from Health IT to specialized fields like biotechnology. Consider if you need a partner with deep scientific knowledge or one with consumer brand experience.
The type of investor matters, too. An individual angel might offer direct mentorship, while a partner at a venture firm brings institutional resources for scaling. As you refine your search, keep these points in mind:
- Expertise Alignment: Does the investor have a background relevant to your product or market?
- Stage and Check Size: Does their typical investment match your current funding round?
- Network and Resources: What can they offer beyond capital, such as industry connections or institutional support?
- Location: Many top investors are in hubs like New York City, which can be a factor for your strategy
Raise Confidently with Rho
Fundraising requires immense focus, and your time is your most valuable asset. This curated list helps you connect with the right investors, so you can direct your energy toward building meaningful relationships.
If you’ve just raised, Rho can help you set up your financial stack in minutes. Our platform provides integrated business banking, corporate cards, and automated bill pay designed for growing startups.
This setup allows you to manage your new capital with clarity and control. Your funding is then put to work on growth and operations, not spent on manual financial tasks.
FAQs about Health Tech Angel Investors
Are there active health tech angel investors in Boston?
Yes, Boston is a major hub for health tech and biotech innovation. Many angel investors and VC firms in Boston actively seek opportunities to fund startups in these sectors, supported by the city's strong research ecosystem.
Do health tech investors fund AI-driven startups?
Many health tech investors show significant interest in companies applying artificial intelligence to solve medical challenges. If your startup uses AI for diagnostics or drug discovery, it can attract investors focused on this intersection.
What is the difference between an angel investor and an early-stage VC?
Angel investors typically invest their own personal funds, often at the pre-seed or seed stage. Early-stage VCs invest from a managed fund, usually writing larger checks and taking a more formal role in governance.
How should I prepare for a Series B round in health tech?
For a Series B round, investors expect to see strong product-market fit and consistent revenue growth. You will need a clear plan for scaling operations, as this funding is meant to accelerate expansion.
How can Rho help after I secure angel funding?
Once you've raised capital, our platform helps you manage it effectively. Rho provides integrated business banking, corporate cards, and AP automation, giving you the financial tools to focus on growth, not administrative tasks.